Tirzepatide shows powerful diabetes-prevention effect in three-year trial 0 26.11.2024 21:45 Sciencedaily.com Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
